Recent Updates
Recently added Catalysts
KIDS Positive Sentiment

OrthoPediatrics Corp. Launches DF2 Brace

Key Takeaway: OrthoPediatrics Corp. has launched the DF2® Brace, a non-surgical solution for femur fracture fixation in pediatric patients aged 6 months to 5 years. This innovative brace replaces the traditional spica cast, offering improved treatment outcomes by providing immobilization and reducing the need for surgery and anesthesia. The DF2 Brace has been clinically studied, demonstrating comparable effectiveness while easing the treatment process for patients and families.
Price reaction · baseline $27.52 (2023-10-09 close) · hit after-hours · 1 other KIDS headline(s) in the window, move may be shared
day 0 close · peak
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • The DF2 Brace offers a significant advancement in treating pediatric femur fractures.
  • It eliminates the need for anesthesia, reducing risks for young patients.
  • The brace has shown equivalent clinical outcomes compared to traditional methods.

Full Press Release Details

WARSAW, Ind., Oct. 10, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the limited release of the DF2® Brace as part of its expansion in the non-surgical business for treating kids with musculoskeletal injuries.
The DF2® Brace is intended for femur fracture fixation in pediatric patients from approximately 6 months to 5 years of age instead of spica cast by providing immobilization of the femur, knee, and hip.
Spica casts for femur fractures are considered the standard of care and have been used for decades, so the DF2® brace represents a significant advancement in how kids with femur fractures can be treated. This specific brace design has been studied in a multi-center trial and demonstrated equivalent outcomes both radiographically and clinically, and in most cases, eliminated the need to proceed to the operating room where the patient undergoes anesthesia.
Joe Hauser, President of Trauma and Deformity Correction at OrthoPediatrics, added, “This is the first product launch for the OrthoPediatrics Specialty Bracing group and will significantly improve the care of kids with femur fractures. The ability to eliminate anesthesia and complications associated with spica casts, all while reducing the overall cost of care is a significant advancement in pediatric orthopedics for patients, their families and surgeons.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 52 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.

Frequently Asked Questions

What is the DF2® Brace designed for?

The DF2® Brace is designed for femur fracture fixation in children aged 6 months to 5 years.

How does DF2® Brace compare to spica casts?

The DF2® Brace offers an alternative to spica casts, providing immobilization without the need for general anesthesia.

What are the benefits of using DF2® Brace?

The DF2® Brace reduces anesthesia risks, complications from spica casts, and overall healthcare costs.

What kind of clinical results does the DF2® Brace show?

In trials, the DF2® Brace demonstrated equivalent clinical and radiographic outcomes compared to traditional methods.

When was OrthoPediatrics Corp. founded?

OrthoPediatrics Corp. was founded in 2006, focusing solely on pediatric orthopedics.

Last updated: Oct 10, 2023